Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, corneal ulcer, fungal keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrome, hypertensive retinopathy, black fungus, traumatic cataract, keratoconus, uveitis, pterygium, blepharitis, posterior subcapsular cataract, rosette cataract, and congenital glaucoma. Dr. Agarwal's Eye Hospital Limited was founded in 1957 and is based in Chennai, India. Dr. Agarwal's Eye Hospital Limited operates as a subsidiary of Dr. Agarwal's Health Care Limited.
| Current Price | ₹5,018.30 |
|---|---|
| Market Cap | ₹2,425 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Healthcare Providers Specialist Services |
| P/E Ratio | 34.1 |
| Return on Equity | 25.22% |
| 52-Week Range | ₹4,142.00 – ₹6,392.00 |
| Beta (1Y) | 0.16 |
| Dividend Yield | 0.16% |
1. Eye Care Related Sales and Services-100%
Dr. Agarwal'S Eye Hospital Ltd is trading at ₹5,018.30, with a market capitalisation of ₹2,425 Cr.
Dr. Agarwal'S Eye Hospital Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Healthcare Providers Specialist Services).
Dr. Agarwal'S Eye Hospital Ltd has a P/E of 34.1 and a return on equity of 25.22%.